| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.02B | — | +13.6% |
| Cost of Revenue | $281.0M | — | +24.3% |
| Gross Profit | $738.0M | — | +10.0% |
| R&D Expense | $164.0M | — | +13.9% |
| SG&A Expense | $88.0M | — | -30.2% |
| Operating Income | $182.0M | — | +65.5% |
| Income Tax | $44.0M | — | +144.4% |
| Net Income | $144.0M | — | +35.8% |
| EPS (Basic) | $0.59 | — | +47.5% |
| EPS (Diluted) | $0.57 | — | +54.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $631.0M | -0.9% | -59.5% |
| Short-term Investments | $59.0M | +18.0% | -18.1% |
| Accounts Receivable | $1.09B | -2.8% | +12.4% |
| Current Assets | $2.09B | -4.9% | -27.2% |
| Total Assets | $3.54B | -4.1% | -17.6% |
| Current Liabilities | $885.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $268.0M | — | -10.1% |
| Capital Expenditures | $16.0M | — | -11.1% |
| Investing Cash Flow | -$8.0M | — | -900.0% |
| Financing Cash Flow | -$328.0M | — | -613.0% |
| Free Cash Flow | $252.0M | — | -10.0% |
| -0.2% |
| Total Liabilities | $941.0M | -3.4% | +1.4% |
| Stockholders' Equity | $2.40B | -4.9% | -24.6% |